Home > Insider Trading > Filing (0001493152-22-015294)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1716947	Ensysce Biosciences Inc.	ENSC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1418785	Lynn Kirkpatrick	C/O Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue, Suite 201 La Jolla CA 92037	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-25	70,000	$0.49	354,851	No	4	P	Direct
Common Stock	Acquisiton	2022-05-26	27,000	$0.53	381,851	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2022-02-17	200,000	$0.00	200,000	$1.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,516,939		2032-02-17	No	4	A	Direct

Footnotes

On February 17, 2022, Dr. Kirkpatrick was granted an option (the "Stock Option") to purchase 200,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter. The Form 4 filed February 24, 2022 included this same information for Table II except for the entry under column 9.